Burkitt lymphoma research in East Africa: Highlights from the 9thAfrican organization for research and training in cancer conference held in Durban, South Africa in 2013

Infectious Agents and Cancer

Volumn 9, Issue 1, 2014, Pages

  Simbiri, Kenneth O ^a   Biddle, Joshua ^b   Kinyera, Tobias ^c   Were, Pamela Akinyi ^d   Tenge, Constance ^e   Kawira, Esther ^f   Masalu, Nestory ^g   Sumba, Peter Odada ^h   Lawler Heavner, Janet ⁱ   Stefan, Cristina D ^j   Buonaguro, Franco M ^k   Robinson, Detra ⁱ   Newton, Robert ^l,m   Harford, Joe ⁿ   Bhatia, Kishor ⁿ   Mbulaiteye, Sam M ⁿ  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Saint Mary Hospital   (Uganda)

^d MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^e MOI UNIVERSITY   (Kenya)

^f EMBLEM Study Shirati Health Education and Development (SHED) Foundation   (Tanzania)

^g Bugando Medical Center   (Tanzania)

^h KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

ⁱ WESTAT   (United States)

^j STELLENBOSCH UNIVERSITY   (South Africa)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l UNIVERSITY OF YORK   (United Kingdom)

^m INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁿ NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; AFRICAN; ARTICLE; BURKITT LYMPHOMA; CANCER PATIENT; CANCER REGISTRY; CANCER RESEARCH; CHILDHOOD CANCER; HUMAN; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; SCIENTIFIC LITERATURE; SOUTH AFRICA; TRAINING; WORKSHOP;

EID: 84907046204     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-9-32     Document Type: Article

References (48)

1. The African organisation for research and training in cancer and its conferences: a historical perspective and highlights of the ninth international conference, Durban, South Africa, 21-24 November 2013. Williams CK, Cristina Stefan D, Rawlinson F, Simbiri K, Mbulaiteye SM, Ecancermedicalscience 2014 8 396 24550997
2. Burkitt Lymphoma: beyond discoveries. Mbulaiteye SM, Infectious agents and cancer 2013 8 1 35 10.1186/1750-9378-8-35 24079372
3. Chemotherapy of jaw lymphomata. Burkitt D, East Afr Med J 1965 42 244 248 14342784
4. Burkitt's lymphoma. Ziegler JL, N Engl J Med 1981 305 13 735 745 10.1056/NEJM198109243051305 7022215
5. Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis. Magrath I, Advances in hematology 2012 2012 130680 22287968
6. A children's cancer dependent on climatic factors. Burkitt D, Nature 1962 194 232 234 10.1038/194232a0 13874900
7. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Epstein MA, Achong BG, Barr YM, Lancet 1964 1 7335 702 703 14107961
8. Viral infections and human cancers: the legacy of Denis Burkitt. Harford JB, Br J Haematol 2012 156 6 709 718 10.1111/j.1365-2141.2011.09017.x 22233526
9. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Bornkamm GW, Semin Cancer Biol 2009 19 6 351 365 10.1016/j.semcancer.2009.07.002 19619654
10. Etiology of Burkitt's lymphoma-an alternative hypothesis to a vectored virus. Burkitt DP, J Natl Cancer Inst 1969 42 1 19 28 4303830
11. Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response. Aka P, Vila MC, Jariwala A, Nkrumah F, Emmanuel B, Yagi M, Palacpac NM, Periago MV, Neequaye J, Kiruthu C, Tougan T, Levine PH, Biggar R, Pfeiffer RM, Bhatia K, Horii T, Bethony J, Mbulaiteye SM, Blood 2013 122 5 629 635 10.1182/blood-2012-12-475665 23645841
12. The immunogenetics of resistance to malaria. Hill AV, Proc Assoc Am Physicians 1999 111 4 272 277 10.1046/j.1525-1381.1999.99234.x 10417733
13. Mendelian randomization as an instrumental variable approach to causal inference. Didelez V, Sheehan N, Stat Methods Med Res 2007 16 4 309 330 10.1177/0962280206077743 17715159
14. Haemoglobin genotypes, ABO blood groups, and Burkitt's tumour. Williams AO, J Med Genet 1966 3 3 177 179 10.1136/jmg.3.3.177 5971054
15. Burkitt's lymphoma and sickle cell trait. Pike MC, Morrow RH, Kisuule A, Mafigiri J, Br J Prev Soc Med 1970 24 1 39 41 5435086
16. Sickle cell trait, hemoglobin C trait, and Burkitt's lymphoma. Nkrumah FK, Perkins IV, AmJTrop Med Hyg 1976 25 4 633 636
17. Malaria resistance genes: a natural selection. Hill AV, Trans R Soc Trop Med Hyg 1992 86 3 225 226 232 10.1016/0035-9203(92)90282-H 1412635
18. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG, Otieno J, Vulule J, Moormann AM, International journal of cancer Journal international du cancer 2014 134 3 645 653 10.1002/ijc.28378 23832374
19. Population genetics of malaria resistance in humans. Hedrick PW, Heredity 2011 107 4 283 304 10.1038/hdy.2011.16 21427751
20. Heritability of malaria in Africa. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, PLoS Med 2005 2 12 340 10.1371/journal.pmed.0020340 16259530
21. A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Baik S, Mbaziira M, Williams M, Ogwang MD, Kinyera T, Emmanuel B, Ziegler JL, Reynolds SJ, Mbulaiteye SM, Infectious agents and cancer 2012 7 1 5 10.1186/1750-9378-7-5 22413839
22. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM, International journal of cancer Journal international du cancer 2008 123 11 2658 2663 10.1002/ijc.23800 18767045
23. Malignant lymphomata involving the jaws in Africa. Burkitt D, J Laryngol Otol 1965 79 11 929 939 10.1017/S0022215100064616 5848032
24. Changes in the presentation of Burkitt's lymphoma in Ghana over a 15-year period (1969-1982). Nkrumah FK, IARC Sci Publ 1984 63 665 674 6536627
25. The use of ultrasound in endemic Burkitt lymphoma in Cameroon. Marjerrison S, Fernandez CV, Price VE, Njume E, Hesseling P, Pediatr Blood Cancer 2012 58 3 352 355 10.1002/pbc.23050 21370431
26. Building capacity for sustainable research programmes for cancer in Africa. Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, Parkin DM, Rebbeck TR, Ross H, Santini LA, Torode J, Trimble EL, Wild CP, Young AM, Kerr DJ, Nat Rev Clin Oncol 2014 11 5 251 259 10.1038/nrclinonc.2014.37 24614139
27. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Ogwang MD, Zhao W, Ayers LW, Mbulaiteye SM, Arch Pathol Lab Med 2011 135 4 445 450 21466360
28. Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Aka P, Kawira E, Masalu N, Emmanuel B, Brubaker G, Magatti J, Mbulaiteye SM, Pediatr Blood Cancer 2012 59 7 1234 1238 10.1002/pbc.24194 22618958
29. 'Triangulating' AMPATH: demonstration of a multi-perspective strategic programme evaluation method. Inui TS, Sidle JE, Nyandiko WM, Yebei VN, Frankel RM, Mossbarger DL, Ayuku D, Ballidawa J, SAHARA J 2009 6 3 105 114 10.1080/17290376.2009.9724938 20485850
30. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, et al. Nature 2012 490 7418 116 120 10.1038/nature11378 22885699
31. Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi. Johnston WT, Mutalima N, Sun D, Emmanuel B, Bhatia K, Aka P, Wu X, Borgstein E, Liomba GN, Kamiza S, Mkandawire N, Batumba M, Carpenter LM, Jaffe H, Molyneux EM, Goedert JJ, Soppet D, Newton R, Mbulaiteye SM, Scientific reports 2014 4 3741 24434689
32. The genetic landscape of mutations in Burkitt lymphoma. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, et al. Nat Genet 2012 44 12 1321 1325 10.1038/ng.2468 23143597
33. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, et al. Nat Genet 2012 44 12 1316 1320 10.1038/ng.2469 23143595
34. New pathogenic mechanisms in Burkitt lymphoma. Campo E, Nat Genet 2012 44 12 1288 1289 10.1038/ng.2476 23192177
35. Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R, Trop Med Int Health 2007 12 8 936 943 10.1111/j.1365-3156.2007.01875.x 17697088
36. Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein-Barr virus. Sumba PO, Kabiru EW, Namuyenga E, Fiore N, Otieno RO, Moormann AM, Orago AS, Rosenbaum PF, Rochford R, Br J Cancer 2010 103 11 1736 1741 10.1038/sj.bjc.6605947 21102592
37. Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana. Tesfalul M, Simbiri K, Wheat CM, Motsepe D, Goldbach H, Armstrong K, Hudson K, Kayembe MK, Robertson E, Kovarik C, Int J Gynecol Cancer 2014 24 4 758 765 10.1097/IGC.0000000000000111 24651632
38. Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients. Simbiri KO, Murakami M, Feldman M, Steenhoff AP, Nkomazana O, Bisson G, Robertson ES, Infectious agents and cancer 2010 5 6 10.1186/1750-9378-5-6 20346104
39. Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights. Wanat KA, Holler PD, Dentchev T, Simbiri K, Robertson E, Seykora JT, Rosenbach M, Arch Dermatol 2012 148 2 219 223 10.1001/archdermatol.2011.1413 22351821
40. Hope for African children with cancer: African pediatric oncology group. Stefan DC, Harford J, Stones D, Newton R, Rodriguez-Galindo C, Pediatr Blood Cancer 2012 59 2 349 10.1002/pbc.24069 22232123
41. Malignancies in South African children with HIV. Davidson A, Wainwright RD, Stones DK, Kruger M, Hendricks M, Geel J, Poole J, Reynders D, Omar F, Mathew R, Stefan DC, J Pediatr Hematol Oncol 2014 36 2 111 117 10.1097/MPH.0b013e31829cdd49 24552745
42. Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Orem J, Sandin S, Weibull CE, Odida M, Wabinga H, Mbidde E, Wabwire-Mangen F, Meijer CJ, Middeldorp JM, Weiderpass E, Clinical epidemiology 2012 4 339 347 23277743
43. Challenges and opportunities for treatment and research of AIDS-related malignancies in Africa. Orem J, Otieno MW, Remick SC, Curr Opin Oncol 2006 18 5 479 486 10.1097/01.cco.0000239887.90665.10 16894296
44. Completeness in an African cancer registry. Parkin DM, Wabinga H, Nambooze S, Cancer Causes Control 2001 12 2 147 152 10.1023/A:1008966225984 11246843
45. Cancer in Africa 2012. Parkin DM, Bray F, Ferlay J, Jemal A, Cancer Epidemiol Biomarkers Prev 2014 23 6 953 966 10.1158/1055-9965.EPI-14-0281 24700176
46. Clinical oncology in resource-limited settings. Buonaguro FM, Gueye SN, Wabinga HR, Ngoma TA, Vermorken JB, Mbulaiteye SM, Infectious agents and cancer 2013 8 1 39 10.1186/1750-9378-8-39 24099039
47. Learning lessons from cancer centers in low- and middle-income countries. Kostelecky B, Trimble EL, Bhatia K, Infectious agents and cancer 2013 8 1 44 10.1186/1750-9378-8-44 24228782
48. Cancer control-planning and monitoring population-based systems. Harford JB, Edwards BK, Nandakumar A, Ndom P, Capocaccia R, Coleman MP, Tumori 2009 95 5 568 578 19999948